Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake-Reference-Cited by-同舟云学术

Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake

Published:2004-11 Issue:11 Volume:25 Page:1077-1081
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Rosário Pedro W.S.,Reis Janice S.,Barroso Álvaro L.,Rezende Leonardo L.,Padrão Eduardo L.,Fagundes Tales A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference34 articles.

1. Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*

2. Papillary and Follicular Thyroid Carcinoma

3. What is the role of 1100 MBq (< 30 mCi) radioiodine 131I in the treatment of patients with differentiated thyroid cancer?

4. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparisons between Criteria for Successful Radioiodine Remnant Ablation in a cohort of Patients with Papillary Thyroid Carcinoma;2024-07-18

2. Radioiodine Theranostics of Differentiated Thyroid Carcinoma;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023

3. Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients;World Journal of Nuclear Medicine;2022-09-05

4. The role of radioactive iodine in the management of patients with differentiated thyroid cancer – An oncologic surgical perspective;European Journal of Surgical Oncology;2020-05

5. Evaluation of customize syringe carriers box for transfering radionuclide iodine-131 in nuclear medicine;Journal of Physics: Conference Series;2020-01-01